209 related articles for article (PubMed ID: 36882503)
1. Celastrol attenuates hepatitis C virus translation and inflammatory response in mice by suppressing heat shock protein 90β.
Chen SR; Li ZQ; Xu J; Ding MY; Shan YM; Cheng YC; Zhang GX; Sun YW; Wang YQ; Wang Y
Acta Pharmacol Sin; 2023 Aug; 44(8):1637-1648. PubMed ID: 36882503
[TBL] [Abstract][Full Text] [Related]
2. Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.
Matsuura K; Sawai H; Ikeo K; Ogawa S; Iio E; Isogawa M; Shimada N; Komori A; Toyoda H; Kumada T; Namisaki T; Yoshiji H; Sakamoto N; Nakagawa M; Asahina Y; Kurosaki M; Izumi N; Enomoto N; Kusakabe A; Kajiwara E; Itoh Y; Ide T; Tamori A; Matsubara M; Kawada N; Shirabe K; Tomita E; Honda M; Kaneko S; Nishina S; Suetsugu A; Hiasa Y; Watanabe H; Genda T; Sakaida I; Nishiguchi S; Takaguchi K; Tanaka E; Sugihara J; Shimada M; Kondo Y; Kawai Y; Kojima K; Nagasaki M; Tokunaga K; Tanaka Y;
Gastroenterology; 2017 May; 152(6):1383-1394. PubMed ID: 28163062
[TBL] [Abstract][Full Text] [Related]
3. A small yeast RNA blocks hepatitis C virus internal ribosome entry site (HCV IRES)-mediated translation and inhibits replication of a chimeric poliovirus under translational control of the HCV IRES element.
Das S; Ott M; Yamane A; Tsai W; Gromeier M; Lahser F; Gupta S; Dasgupta A
J Virol; 1998 Jul; 72(7):5638-47. PubMed ID: 9621022
[TBL] [Abstract][Full Text] [Related]
4. The interaction between human initiation factor eIF3 subunit c and heat-shock protein 90: a necessary factor for translation mediated by the hepatitis C virus internal ribosome entry site.
Ujino S; Nishitsuji H; Sugiyama R; Suzuki H; Hishiki T; Sugiyama K; Shimotohno K; Takaku H
Virus Res; 2012 Jan; 163(1):390-5. PubMed ID: 22016036
[TBL] [Abstract][Full Text] [Related]
5. Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients.
Cabibbo G; Celsa C; Calvaruso V; Petta S; Cacciola I; Cannavò MR; Madonia S; Rossi M; Magro B; Rini F; Distefano M; Larocca L; Prestileo T; Malizia G; Bertino G; Benanti F; Licata A; Scalisi I; Mazzola G; Di Rosolini MA; Alaimo G; Averna A; Cartabellotta F; Alessi N; Guastella S; Russello M; Scifo G; Squadrito G; Raimondo G; Trevisani F; Craxì A; Di Marco V; Cammà C;
J Hepatol; 2019 Aug; 71(2):265-273. PubMed ID: 30959157
[TBL] [Abstract][Full Text] [Related]
6. Celastrol inhibits hepatitis C virus replication by upregulating heme oxygenase-1 via the JNK MAPK/Nrf2 pathway in human hepatoma cells.
Tseng CK; Hsu SP; Lin CK; Wu YH; Lee JC; Young KC
Antiviral Res; 2017 Oct; 146():191-200. PubMed ID: 28935193
[TBL] [Abstract][Full Text] [Related]
7. Involvement of heat shock protein (Hsp)90 beta but not Hsp90 alpha in antiapoptotic effect of CpG-B oligodeoxynucleotide.
Kuo CC; Liang CM; Lai CY; Liang SM
J Immunol; 2007 May; 178(10):6100-8. PubMed ID: 17475835
[TBL] [Abstract][Full Text] [Related]
8. HSP90β Impedes STUB1-Induced Ubiquitination of YTHDF2 to Drive Sorafenib Resistance in Hepatocellular Carcinoma.
Liao Y; Liu Y; Yu C; Lei Q; Cheng J; Kong W; Yu Y; Zhuang X; Sun W; Yin S; Cai G; Huang H
Adv Sci (Weinh); 2023 Sep; 10(27):e2302025. PubMed ID: 37515378
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus leaves an epigenetic signature post cure of infection by direct-acting antivirals.
Perez S; Kaspi A; Domovitz T; Davidovich A; Lavi-Itzkovitz A; Meirson T; Alison Holmes J; Dai CY; Huang CF; Chung RT; Nimer A; El-Osta A; Yaari G; Stemmer SM; Yu ML; Haviv I; Gal-Tanamy M
PLoS Genet; 2019 Jun; 15(6):e1008181. PubMed ID: 31216276
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C Virus-Associated Cancers.
Yi Z; Yuan Z
Adv Exp Med Biol; 2017; 1018():129-146. PubMed ID: 29052135
[TBL] [Abstract][Full Text] [Related]
11. Interferon regulatory factor 5 (IRF5) suppresses hepatitis C virus (HCV) replication and HCV-associated hepatocellular carcinoma.
Cevik O; Li D; Baljinnyam E; Manvar D; Pimenta EM; Waris G; Barnes BJ; Kaushik-Basu N
J Biol Chem; 2017 Dec; 292(52):21676-21689. PubMed ID: 29079574
[TBL] [Abstract][Full Text] [Related]
12. Influence of hepatitis C virus infection on circulating levels of sICAM-1 and VEGF in patients with hepatitis C and hepatocellular carcinoma (HCC) and their role in enhancing detection of HCC.
Helaly GF; Abou Shamaa LA
Egypt J Immunol; 2006; 13(1):27-38. PubMed ID: 17974148
[TBL] [Abstract][Full Text] [Related]
13. Hsp90β promotes aggressive vasculogenic mimicry via epithelial-mesenchymal transition in hepatocellular carcinoma.
Meng J; Chen S; Lei YY; Han JX; Zhong WL; Wang XR; Liu YR; Gao WF; Zhang Q; Tan Q; Liu HJ; Zhou HG; Sun T; Yang C
Oncogene; 2019 Jan; 38(2):228-243. PubMed ID: 30087438
[TBL] [Abstract][Full Text] [Related]
14. Novel complementary antitumour effects of celastrol and metformin by targeting IκBκB, apoptosis and NLRP3 inflammasome activation in diethylnitrosamine-induced murine hepatocarcinogenesis.
Saber S; Ghanim AMH; El-Ahwany E; El-Kader EMA
Cancer Chemother Pharmacol; 2020 Feb; 85(2):331-343. PubMed ID: 31989218
[TBL] [Abstract][Full Text] [Related]
15. The impact of the revolution in hepatitis C treatment on hepatocellular carcinoma.
Wirth TC; Manns MP
Ann Oncol; 2016 Aug; 27(8):1467-74. PubMed ID: 27226385
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
Chen DS
Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
[TBL] [Abstract][Full Text] [Related]
17. HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response.
Hamdane N; Jühling F; Crouchet E; El Saghire H; Thumann C; Oudot MA; Bandiera S; Saviano A; Ponsolles C; Roca Suarez AA; Li S; Fujiwara N; Ono A; Davidson I; Bardeesy N; Schmidl C; Bock C; Schuster C; Lupberger J; Habersetzer F; Doffoël M; Piardi T; Sommacale D; Imamura M; Uchida T; Ohdan H; Aikata H; Chayama K; Boldanova T; Pessaux P; Fuchs BC; Hoshida Y; Zeisel MB; Duong FHT; Baumert TF
Gastroenterology; 2019 Jun; 156(8):2313-2329.e7. PubMed ID: 30836093
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C: From inflammatory pathogenesis to anti-inflammatory/hepatoprotective therapy.
Li H; Huang MH; Jiang JD; Peng ZG
World J Gastroenterol; 2018 Dec; 24(47):5297-5311. PubMed ID: 30598575
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of HSP90β Improves Lipid Disorders by Promoting Mature SREBPs Degradation via the Ubiquitin-proteasome System.
Zheng ZG; Zhang X; Liu XX; Jin XX; Dai L; Cheng HM; Jing D; Thu PM; Zhang M; Li H; Zhu J; Liu C; Xue B; Li Y; Chen L; Peng C; Zhu W; Wang L; Liu J; Li HJ; Li P; Xu X
Theranostics; 2019; 9(20):5769-5783. PubMed ID: 31534518
[No Abstract] [Full Text] [Related]
20. Hepatitis virus infection affects DNA methylation in mice with humanized livers.
Okamoto Y; Shinjo K; Shimizu Y; Sano T; Yamao K; Gao W; Fujii M; Osada H; Sekido Y; Murakami S; Tanaka Y; Joh T; Sato S; Takahashi S; Wakita T; Zhu J; Issa JP; Kondo Y
Gastroenterology; 2014 Feb; 146(2):562-72. PubMed ID: 24184133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
